1. Home
  2. AURA vs CHPT Comparison

AURA vs CHPT Comparison

Compare AURA & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AURA
  • CHPT
  • Stock Information
  • Founded
  • AURA 2007
  • CHPT 2007
  • Country
  • AURA United States
  • CHPT United States
  • Employees
  • AURA N/A
  • CHPT N/A
  • Industry
  • AURA Biotechnology: Pharmaceutical Preparations
  • CHPT Industrial Specialties
  • Sector
  • AURA Health Care
  • CHPT Consumer Discretionary
  • Exchange
  • AURA Nasdaq
  • CHPT Nasdaq
  • Market Cap
  • AURA 370.1M
  • CHPT 321.7M
  • IPO Year
  • AURA 2021
  • CHPT N/A
  • Fundamental
  • Price
  • AURA $6.16
  • CHPT $0.69
  • Analyst Decision
  • AURA Strong Buy
  • CHPT Hold
  • Analyst Count
  • AURA 5
  • CHPT 10
  • Target Price
  • AURA $22.60
  • CHPT $1.58
  • AVG Volume (30 Days)
  • AURA 243.1K
  • CHPT 10.8M
  • Earning Date
  • AURA 05-15-2025
  • CHPT 06-04-2025
  • Dividend Yield
  • AURA N/A
  • CHPT N/A
  • EPS Growth
  • AURA N/A
  • CHPT N/A
  • EPS
  • AURA N/A
  • CHPT N/A
  • Revenue
  • AURA N/A
  • CHPT $417,083,000.00
  • Revenue This Year
  • AURA N/A
  • CHPT $12.03
  • Revenue Next Year
  • AURA N/A
  • CHPT $26.85
  • P/E Ratio
  • AURA N/A
  • CHPT N/A
  • Revenue Growth
  • AURA N/A
  • CHPT N/A
  • 52 Week Low
  • AURA $4.35
  • CHPT $0.51
  • 52 Week High
  • AURA $12.38
  • CHPT $2.44
  • Technical
  • Relative Strength Index (RSI)
  • AURA 56.59
  • CHPT 51.68
  • Support Level
  • AURA $5.68
  • CHPT $0.67
  • Resistance Level
  • AURA $6.30
  • CHPT $0.79
  • Average True Range (ATR)
  • AURA 0.48
  • CHPT 0.05
  • MACD
  • AURA 0.07
  • CHPT 0.00
  • Stochastic Oscillator
  • AURA 88.75
  • CHPT 23.51

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

About CHPT ChargePoint Holdings Inc.

ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.

Share on Social Networks: